Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Frontiers in Medicine|August 15, 2024
Advances in hepatocellular carcinoma drug resistance modelsYien Xiang, Jun Wu, Hanjiao QinCellular Signalling|September 15, 2024
Long non-coding RNA LNC-POTEM-4 promotes HCC progression via the LNC-POTEM-4/miR-149-5p/Wnt4 signaling axisChao Lin, Jiacheng Wu, Zhixuan Wang, et al.Frontiers in Neuroscience|August 9, 2018
Neural Mechanisms With Respect to Different Paradigms and Relevant Regulatory Factors in Empathy for PainYien Xiang, Yicun Wang, Shuohui Gao, et al.Journal of Physiology and Biochemistry|January 30, 2020
MiR-23a-3p promoted G1/S cell cycle transition by targeting protocadherin17 in hepatocellular carcinomaYien Xiang, Yongsheng Yang, Chao Lin, et al.Frontiers in Oncology|May 27, 2022
Advances in Renal Cell Carcinoma Drug Resistance ModelsYien Xiang, Ge Zheng, Jianfeng Zhong, et al.Gels (Basel, Switzerland)|June 26, 2026
Design-Driven Gel-Based Delivery Systems for Bioactives in Sports NutritionYien Xiang, Fan Yao, Xin Jin, et al.Biomed Research International|December 31, 2019
Bioinformatic Analysis of Circular RNA-Associated ceRNA Network Associated with Hepatocellular CarcinomaJiacheng Wu, Shui Liu, Yien Xiang, et al.Journal of Physiology and Biochemistry|July 5, 2020
Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axisChao Lin, Yien Xiang, Jiyao Sheng, et al.Cancer Cell International|June 1, 2024
LncRNA CRNDE promotes hepatoma cell proliferation by regulating the metabolic reprogramming of M2 macrophages via ERK pathwayChao Lin, Tao Jiang, Changyong E, et al.Journal of Immunology Research|May 23, 2018
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future ExpectationsYingjun Xie, Yien Xiang, Jiyao Sheng, et al.Pageof 2